Brave Asset Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55K | Sell |
25,000
-10,000
| -29% | -$22K | 0.01% | 151 |
|
|
2025
Q1 | $40.6K | Buy |
35,000
+25,000
| +250% | +$29K | 0.01% | 143 |
|
|
2024
Q4 | $12.7K | Sell |
10,000
-725
| -7% | -$921 | ﹤0.01% | 159 |
|
|
2024
Q3 | $36.6K | Hold |
10,725
| – | – | 0.01% | 152 |
|
|
2024
Q2 | $50.1K | Hold |
10,725
| – | – | 0.01% | 144 |
|
|
2024
Q1 | $79.6K | Hold |
10,725
| – | – | 0.02% | 144 |
|
|
2023
Q4 | $109K | Hold |
10,725
| – | – | 0.03% | 135 |
|
|
2023
Q3 | $83.7K | Hold |
10,725
| – | – | 0.03% | 129 |
|
|
2023
Q2 | $88.3K | Buy |
+10,725
| New | +$88.3K | 0.03% | 133 |
|